Once-Weekly Efsitora Noninferior to Daily Insulin in T2D

The once-weekly insulin analog lowered A1c as effectively as once-daily formulations in three new trials in type 2 diabetes.
Medscape Medical News

source https://www.medscape.com/viewarticle/once-weekly-efsitora-noninferior-daily-insulin-t2d-2025a1000gm1?src=rss